Investigation of the molecular mechanisms for the development of osteosarcoma using the retinoblastoma gene chimeric mice.

使用视网膜母细胞瘤基因嵌合小鼠研究骨肉瘤发生的分子机制。

基本信息

  • 批准号:
    10470306
  • 负责人:
  • 金额:
    $ 6.66万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    1998
  • 资助国家:
    日本
  • 起止时间:
    1998 至 1999
  • 项目状态:
    已结题

项目摘要

To investigate the role of the retinobastoma (Rb) gene in the process of oncogenesis, we have performed the in vitro transformation experiments using the Rb(-/-) osteoblast as a starting material. First, we have created the Rb chimeric mice consisted of Rb(+/+) and Rb(-/-) cells by using Rb(-/-) ES cells. The Rb(-/-) osteoblasts were isolated from Calvary and long bones from newborn chimeric mice, and several clones were established. The genotypes of these clonal cells were analyzed by the allelespecific PCR and Rb(-/-) clones were further studied. The level of alkaline phosphatase (ALP) and osteocalcin, which are considered to be markers for differentiated-osteoblasts, were relatively low, whereas the expression the cbfal and BMP2 genes were almost equivalent with those of the Rb(+/+) osteoblastic cells.By the differentiation-induction experiments, these cells showed increased ALP activity and produced mineralized matrix, suggesting that the Rb deficiency has no remarkable effects for the differentiaotn process of osteoblasts. We found that these cells showed marked reduction of growth ability when the generation number was over 90, which is thought to be the life span of normal rodent cells, indicating that the Rb deficiency has no remarkable effects for the immortality. We are currently creating the tetracycline-regulated Rb expression system in these cells to further investigate the phenotypic differences of Rb(+/+) and Rb(-/-) osteoblasts, such as the response for growth factors.On the other hand, to obtain fully transformed cells, the dominant negative mutant of the human p53 gene was transfected into these cells. Transformants showed persistent growth ability even after the 90ィイD1thィエD1 generations, suggesting that the mutant p53 confer the immortality to these cells. We are currently analyzing the in vitro and in vivo phenotypes as fully neoplastic cells of these transfectants.
为了研究视网膜母细胞瘤(retinobastoma,Rb)基因在肿瘤发生过程中的作用,我们以Rb(-/-)成骨细胞为起始材料进行了体外转化实验。首先,我们利用Rb(-/-)ES细胞建立了由Rb(+/+)和Rb(-/-)细胞组成的Rb嵌合小鼠。从新生嵌合体小鼠的跟骨和长骨中分离Rb(-/-)成骨细胞,并建立了几个克隆。用等位基因特异性PCR分析克隆细胞的基因型,并进一步研究Rb(-/-)克隆。分化成骨细胞的标志物碱性磷酸酶(ALP)和骨钙素水平较低,而cbfal和BMP 2基因的表达与Rb(+/+)成骨细胞相当,诱导分化实验显示,这些细胞ALP活性增强,并产生矿化基质,提示Rb缺乏对成骨细胞的分化过程无明显影响。我们发现,当细胞的世代数超过90代时,细胞的生长能力明显下降,这被认为是正常啮齿动物细胞的寿命,表明Rb缺乏对永生性没有明显影响。为了进一步研究Rb(+/+)和Rb(-/-)成骨细胞表型的差异,如对生长因子的反应,我们目前正在这些细胞中建立四环素调控的Rb表达系统。另一方面,为了获得完全转化的细胞,将人p53基因的显性负突变体转染这些细胞。即使在第90代イD1 D1代之后,转化体仍表现出持续的生长能力,这表明突变型p53赋予这些细胞永生性。我们目前正在分析在体外和体内的表型作为完全肿瘤细胞的这些转染。

项目成果

期刊论文数量(24)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kanoe H.et al.: "Amplification of the CDK4 gene in sarcomas: tumar specificity and relationship with the RB gene mutation"Anticancer Res.. 18. 2317-2322 (1998)
Kanoe H.等人:“肉瘤中 CDK4 基因的扩增:肿瘤特异性以及与 RB 基因突变的关系”Anticancer Res. 18. 2317-2322 (1998)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kanoe, H., et al.: "Charactreristics of genomic breakpoints in TLS-CHOP translocations in liposarcomas suggest the imvolvement of Translin and topoisererase II in the process of translocation" Oncogene. 18(3). 721-729 (1999)
Kanoe, H. 等人:“脂肪肉瘤中 TLS-CHOP 易位基因组断点的特征表明 Translin 和拓扑酶 II 在易位过程中的参与”Oncogene。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Nakamura,I., et al.: "Associafion of the human NPPS gene with ossificafion of the posterior longitudinal ligament ot the spino (OPLL)"Hum. Genet.. 104. 492-497 (1999)
Nakamura,I., et al.:“人类 NPPS 基因与脊柱后纵韧带骨化 (OPLL) 的关联”Hum。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hoshikawa, H., et al.: "High affinity binding of oxidized LDL to mause lectin-like oxidized LDL receptor(LDX-1)" Biochem.Biophys.Res.Commun.245(3). 841-846 (1998)
Hoshikawa, H. 等人:“氧化 LDL 与小鼠凝集素样氧化 LDL 受体 (LDX-1) 的高亲和力结合”Biochem.Biophys.Res.Commun.245(3)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yamamoto,H., et al.: "High incidence of SV40・like sequprces detedion in tumour and peripheral blood cells of Japanese osteosarcome patients"Br. J. Cancer. (in press).
Yamamoto, H. 等人:“日本骨肉瘤患者的肿瘤和外周血细胞中 SV40 样序列检测的高发生率”Br. J. Cancer(出版中)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TOGUCHIDA Junya其他文献

TOGUCHIDA Junya的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TOGUCHIDA Junya', 18)}}的其他基金

Investigation for the pathomechanism of cartilage-forming tumors by whole exome sequencing
全外显子组测序研究软骨形成肿瘤的发病机制
  • 批准号:
    24390353
  • 财政年份:
    2012
  • 资助金额:
    $ 6.66万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Establishment of canine iPS cells for the study of disease-model dogs
建立犬 iPS 细胞用于研究疾病模型犬
  • 批准号:
    24659675
  • 财政年份:
    2012
  • 资助金额:
    $ 6.66万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Identification of cell-of-origin of sarcomas using human iPS cells containing inducible expression vectors
使用含有诱导表达载体的人 iPS 细胞鉴定肉瘤细胞起源
  • 批准号:
    22659272
  • 财政年份:
    2010
  • 资助金额:
    $ 6.66万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Establishment of mouse model of synovial sarcomas using lineage-specific gene targeting system
利用谱系特异性基因打靶系统建立小鼠滑膜肉瘤模型
  • 批准号:
    21390420
  • 财政年份:
    2009
  • 资助金额:
    $ 6.66万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
In vitro transformation of mesenchymal stem cell : the exploration of molecular mechanism and the development of monitoring system
间充质干细胞体外转化:分子机制探索及监测系统开发
  • 批准号:
    18390414
  • 财政年份:
    2006
  • 资助金额:
    $ 6.66万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of personalized methods for the diagnosis and treatment for bone and soft tissue sarcomas
开发骨和软组织肉瘤的个性化诊断和治疗方法
  • 批准号:
    17015023
  • 财政年份:
    2005
  • 资助金额:
    $ 6.66万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
Development of the treatment for cartilage regeneration by a prostanoid signal-acting material
通过前列腺素信号作用材料开发软骨再生治疗方法
  • 批准号:
    16390437
  • 财政年份:
    2004
  • 资助金额:
    $ 6.66万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Investigation of the mechanism of proliferation and differentiation of cartilage tissue using chondrocytes derived from p53-/-mouse.
使用p53-/-小鼠来源的软骨细胞研究软骨组织的增殖和分化机制。
  • 批准号:
    14380399
  • 财政年份:
    2002
  • 资助金额:
    $ 6.66万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular cloning and mutation analyses of novel genes involving the development and progression of osteosarcoma
涉及骨肉瘤发生发展的新基因的分子克隆和突变分析
  • 批准号:
    12470307
  • 财政年份:
    2000
  • 资助金额:
    $ 6.66万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of antisense therapy for solid tumors with reciplocal translocation
相互易位实体瘤反义疗法的发展
  • 批准号:
    08557085
  • 财政年份:
    1996
  • 资助金额:
    $ 6.66万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)

相似海外基金

Investigation of the Retinoblastoma gene using fruit flies as a model organism
使用果蝇作为模式生物研究视网膜母细胞瘤基因
  • 批准号:
    213312
  • 财政年份:
    2010
  • 资助金额:
    $ 6.66万
  • 项目类别:
    Salary Programs
RETINOBLASTOMA GENE IN INFLAMMATION AND CANCER
炎症和癌症中的视网膜母细胞瘤基因
  • 批准号:
    7610471
  • 财政年份:
    2007
  • 资助金额:
    $ 6.66万
  • 项目类别:
COBRE: USC: RETINOBLASTOMA GENE IN INFLAMMATION AND CANCER
COBRE:南加州大学:炎症和癌症中的视网膜母细胞瘤基因
  • 批准号:
    7381897
  • 财政年份:
    2006
  • 资助金额:
    $ 6.66万
  • 项目类别:
Role of retinoblastoma gene product in embryo development
视网膜母细胞瘤基因产物在胚胎发育中的作用
  • 批准号:
    nhmrc : 358798
  • 财政年份:
    2005
  • 资助金额:
    $ 6.66万
  • 项目类别:
    NHMRC Postgraduate Scholarships
COBRE: USC: RETINOBLASTOMA GENE IN INFLAMMATION AND CANCER
COBRE:南加州大学:炎症和癌症中的视网膜母细胞瘤基因
  • 批准号:
    7171123
  • 财政年份:
    2005
  • 资助金额:
    $ 6.66万
  • 项目类别:
CELLULAR FUNCTION OF THE RETINOBLASTOMA GENE PRODUCT
视网膜母细胞瘤基因产物的细胞功能
  • 批准号:
    2099023
  • 财政年份:
    1994
  • 资助金额:
    $ 6.66万
  • 项目类别:
Biological Function of the Retinoblastoma Gene Product
视网膜母细胞瘤基因产物的生物学功能
  • 批准号:
    8061985
  • 财政年份:
    1994
  • 资助金额:
    $ 6.66万
  • 项目类别:
CELLULAR FUNCTION OF THE RETINOBLASTOMA GENE PRODUCT
视网膜母细胞瘤基因产物的细胞功能
  • 批准号:
    2099024
  • 财政年份:
    1994
  • 资助金额:
    $ 6.66万
  • 项目类别:
CELLULAR FUNCTION OF THE RETINOBLASTOMA GENE PRODUCT
视网膜母细胞瘤基因产物的细胞功能
  • 批准号:
    2099025
  • 财政年份:
    1994
  • 资助金额:
    $ 6.66万
  • 项目类别:
BIOLOGICAL Function of the Retinoblastoma Gene Product
视网膜母细胞瘤基因产物的生物学功能
  • 批准号:
    6709394
  • 财政年份:
    1994
  • 资助金额:
    $ 6.66万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了